These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 7665142

  • 1. Thymoma--a study of 60 cases in Singapore.
    Tan PH, Sng IT.
    Histopathology; 1995 Jun; 26(6):509-18. PubMed ID: 7665142
    [Abstract] [Full Text] [Related]

  • 2. Thymoma. Histologic subclassification is an independent prognostic factor.
    Quintanilla-Martinez L, Wilkins EW, Choi N, Efird J, Hug E, Harris NL.
    Cancer; 1994 Jul 15; 74(2):606-17. PubMed ID: 8033040
    [Abstract] [Full Text] [Related]

  • 3. Thymoma--morphologic subclassification correlates with invasiveness and immunohistologic features: a study of 122 cases.
    Quintanilla-Martinez L, Wilkins EW, Ferry JA, Harris NL.
    Hum Pathol; 1993 Sep 15; 24(9):958-69. PubMed ID: 8253462
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathological study of thymomas--correlation of histologic subtype to myasthenia gravis and prognosis.
    Sundaram C, Rajagopal P, Rakshak AD, Omprakash G, Das SM, Murthy JM.
    Indian J Pathol Microbiol; 2003 Jul 15; 46(3):378-81. PubMed ID: 15025278
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of a histogenetic classification for thymic epithelial tumours.
    Ho FC, Fu KH, Lam SY, Chiu SW, Chan AC, Müller-Hermelink HK.
    Histopathology; 1994 Jul 15; 25(1):21-9. PubMed ID: 7959642
    [Abstract] [Full Text] [Related]

  • 6. Thymoma: a study of the pathologic classification of 71 cases with evaluation of the Muller-Hermelink system.
    Kuo TT, Lo SK.
    Hum Pathol; 1993 Jul 15; 24(7):766-71. PubMed ID: 8319955
    [Abstract] [Full Text] [Related]

  • 7. Malignant grading of cortical and medullary differentiated thymoma by morphometric analysis.
    Nomori H, Ishihara T, Torikata C.
    Cancer; 1989 Oct 15; 64(8):1694-9. PubMed ID: 2676138
    [Abstract] [Full Text] [Related]

  • 8. [Morphometrical and immunohistochemical analysis of cortical and medullary thymoma: its correlation with invasiveness and association with myasthenia gravis].
    Nomori H, Ishihara T, Torikata C.
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Jan 15; 38(1):93-100. PubMed ID: 1691772
    [Abstract] [Full Text] [Related]

  • 9. DNA-ploidy analysis correlates with the histogenetic classification of thymic epithelial tumours.
    Gschwendtner A, Fend F, Hoffmann Y, Krugmann J, Klingler PJ, Mairinger T.
    J Pathol; 1999 Dec 15; 189(4):576-80. PubMed ID: 10629561
    [Abstract] [Full Text] [Related]

  • 10. Thymomas and thymic carcinomas. Evaluation of the Müller-Hermelink classification.
    Papla B, Rudnicka L, Dubiel-Bigaj M, Malinowski E.
    Pol J Pathol; 1998 Dec 15; 49(4):251-65. PubMed ID: 10323079
    [Abstract] [Full Text] [Related]

  • 11. Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus.
    Marino M, Müller-Hermelink HK.
    Virchows Arch A Pathol Anat Histopathol; 1985 Dec 15; 407(2):119-49. PubMed ID: 3927579
    [Abstract] [Full Text] [Related]

  • 12. Invasive medullary thymoma associated with Myasthenia gravis: an unusual case.
    Reis Filho JS, Milanezi MF, Moreira CG, Werneck LC, Boscardin P, Ioshii SO, Schmitt FC.
    Arq Neuropsiquiatr; 2000 Dec 15; 58(4):1110-4. PubMed ID: 11105080
    [Abstract] [Full Text] [Related]

  • 13. Controversies regarding the pathology of thymomas.
    Kornstein MJ.
    Pathol Annu; 1992 Dec 15; 27 Pt 2():1-15. PubMed ID: 1584624
    [No Abstract] [Full Text] [Related]

  • 14. Thymoma: a pathological study of 50 cases.
    Vaideeswar P, Padmanabhan A, Deshpande JR, Pandit SP.
    J Postgrad Med; 2004 Dec 15; 50(2):94-7. PubMed ID: 15235201
    [Abstract] [Full Text] [Related]

  • 15. [Expression of CD20 in thymomas and its clinical implication].
    Du J, Zhou XJ, Yin HL, Lu ZF, Zhou HB.
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep 15; 39(9):611-4. PubMed ID: 21092589
    [Abstract] [Full Text] [Related]

  • 16. PE-35-related antigen expression and CD1a-positive lymphocytes in thymoma subtypes based on Müller-Hermelink classification. An immunohistochemical study using catalyzed signal amplification.
    Hattori H, Tateyama H, Tada T, Saito Y, Yamakawa Y, Eimoto T.
    Virchows Arch; 2000 Jan 15; 436(1):20-7. PubMed ID: 10664158
    [Abstract] [Full Text] [Related]

  • 17. Thymoma: a clinico-pathologic study based on newly developed morphologic criteria.
    Rendina EA, Pescarmona EO, Venuta F, Nardi S, De Rosa G, Martelli M, Ricci C.
    Tumori; 1988 Feb 29; 74(1):79-84. PubMed ID: 3354066
    [Abstract] [Full Text] [Related]

  • 18. Prognostic importance of histomorphologic subclassification for epithelial thymic tumors.
    Schneider PM, Fellbaum C, Fink U, Bollschweiler E, Präuer HW.
    Ann Surg Oncol; 1997 Jan 29; 4(1):46-56. PubMed ID: 8985517
    [Abstract] [Full Text] [Related]

  • 19. Pathological aspects of malignant and benign thymic disorders.
    Müller-Hermelink HK, Marx A.
    Ann Med; 1999 Oct 29; 31 Suppl 2():5-14. PubMed ID: 10574149
    [Abstract] [Full Text] [Related]

  • 20. The clinicopathological correlation of epithelial subtyping in thymoma: a study of 112 consecutive cases.
    Pan CC, Wu HP, Yang CF, Chen WY, Chiang H.
    Hum Pathol; 1994 Sep 29; 25(9):893-9. PubMed ID: 8088764
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.